Utilizing the PS Gene Editing System to Encode a Blood‐Brain Barrier‐Penetrating IDUA as a Treatment for Murine Hurler Syndrome

Awardee: Michael Przybilla

Institution: University of Minnesota

Award Amount: $165,000

Funding Period: February 1, 2023 - January 31, 2024

Previous
Previous

Biochemical investigation of NUBPL disease mechanisms and therapy candidates

Next
Next

The new lysosomal activator GHF201 (144DG11) as a potential treatment for mucopolysaccharidosis I”